A Clinical Study of efficacy of Nisha-Amalaki churna in on insulin resistance in overweight subjects

Randomised Controlled Clinical Study of Efficacy of Nisha-Amalaki Churna on Insulin Resistance in Overweight subjects with special reference to Sthaulya

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052259

Enrollment

Registered

2023-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are fulfilling above mentioned diagnostic criteria 2. Patients who are willing for treatment 3. Patients irrespective of their sex, religion and socioeconomic status. 4. Patients between age group 18-60 5. BMI 23 TO 35

Exclusion criteria

Exclusion criteria: 1. Patients with chronic alcoholism 2. Patients with infectious disorder 3. Patients with multiple drug therapy/steroids 4. Pregnant or lactating women 5. Critically ill patients 6. Patients having clinical condition which may interact with either insulin levels or drug action

Design outcomes

Primary

Measure	Time frame
To study the effect of Nisha-Amalaki churna on HOMA-IR in overweight subjects Timepoint: 45 days	—

Secondary

Measure	Time frame
1) To evaluate the effect of Nisha- Amalaki churna on symptoms of sthaulya. 2) To see the effect of Nisha- Amalaki churna on hematological parameter (fasting plasma insulin level, ESR, BSL fasting and post prandial)Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDrVS Boinwad

Government Ayurvedic College Nanded

vidya.shyam.kore@gmail.com9503609432

Outcome results